O gênero Psidium é pertencente à família Myrtaceae e compreende importantes espécies botânicas, destacando-se a goiabeira (Psidium guajava L.). O óleo essencial (OE) desta espécie já conduziu diversos trabalhos científicos devido a sua composição química e propriedades farmacológicas, destacando-se a sua ação antifúngica e atividades antimicrobianas. Neste trabalho, duas variedades de Psidium, Psidium guajava var. pomifera (Paluma) e Psidium guajava var. pyrifera (Kumagai), foram coletadas em diferentes localidades do município de Itacoatiara – AM, o OE das folhas foram avaliadas quanto à composição química e atividade antimicrobiana. A extração do óleo essencial foi realizada por hidrodestilação em aparelho do tipo Clevenger durante 4 horas, as análises quantitativas e qualitativas foram executadas por cromatografia gasosa acoplada à espectrometria de massa. As atividades antimicrobianas foram avaliadas utilizando o teste in vitro sobre a inibição do crescimento bacteriano de Escherichia coli (Migula 1895) Castellani e Chalmers 1919, Salmonella sp e Staphylococcus aureus Rosenbach 1884 e do crescimento micelial dos fitopatógenos Candida albicans (C.P. Robin) Berkhout 1923 e Candida parapsilosis (Ashford) Langeron & Talice 1932. A composição química revelou a presença dos monoterpenos: D_limoneno, α-pineno, 1,8 – cineol, e dos sequiterpenos: trans-nerolidol, trans-cariofileno, óxido de cariofileno e α-Humuleno como constituintes majoritários nas amostras avaliadas. Em relação aos testes biológicos realizados foi possível observar atividade antimicrobiana em todas as cepas estudadas. Diante dos resultados, conclui-se que óleos essenciais destas variedades de P. guajava apresentam atividades promissoras e podem ser consideradas como nova fonte de compostos bioativos antimicrobianos.
28 September 2016 in African Journal of Microbiology Research
The microbial community structure from dark earth in a native archaeological site of the Lower Amazon was analyzed by PCR-DGGE, using 16S rRNA gene for prokaryote population and 18S rDNA and ITS regions (using clamp GC) for the eukaryote population. The bands were excised from gel and re-amplified for sequencing. The diversity found according to the region of amplification showed same profiles for the two primers pairs. The bacteria genus were: Bacillus, Klebsiella, Pantoea, Enterobacter, Lactobacillus, Escherichia, Leuconostoc and actinobacterias as Streptomyces and Microbacterium. Among the fungal community was Zygosaccharomyces, Lachancea, Saccharomyces, Cladosporium, Candida, Penicillium and Uncultured ascomycota and zygomycete were found. Molecular approaches revealed microbial groups that have never been reported in Lower Amazon soil as the Leuconostoc mesenteroides, Lactobacillus casei and Lactobacillus paracasei bacteria’s and Lachancea meyersii yeast. The soil pH was ~6.5; the soil had high levels of minerals with exception of Na (not detected) and Al (~0.2 mg/dm3). The organic matter was 3.5 dag/kg. This study also shows that the Amazon soil is rich in minerals. This can be an important factor in the species richness in the Amazon region. The present data show that the Lower Amazon represents a vast resource for the biotechnology area. Key words: PCR-DGGE, fungi and yeast, soil microdiversity, soil chemical.
Microbial natural products are central to drug discovery, yet many biosynthetic gene clusters remain transcriptionally silent under standard laboratory conditions. Conventional screening workflows—based on ex situ cultivation and metabolite extraction—can be labor-intensive and often fail to capture ecologically relevant microbial interactions. To address these limitations, we propose the aNP-TRAP (Activity-guided Natural Product Triaging and Recognition Assay Platform), a conceptual, field-deployable device designed to integrate in situ microbial cultivation with functional detection of bioactivity. The system consists of a honeycomb array of cultivation wells, semipermeable and gradient membranes to permit directional metabolite diffusion, and a detection layer containing biosensors responsive to antibacterial, antifungal, or quorum-sensing–inhibitory compounds. Three detection strategies are envisioned: Escherichia coli JW5503-1 with resazurin for antibacterial activity, Candida albicans for antifungal screening, and Chromobacterium violaceum CV026 for quorum-sensing inhibition. Microbial metabolites diffusing through the membranes interact with the biosensor matrices, potentially generating colorimetric or pigment-based signals. This platform is conceptual and currently lacks empirical validation; all performance expectations derive from simulation-based reasoning. In brief, simulations suggested a 0.2 µm membrane equilibrates nutrients within ∼2–6 h, directional metabolite flux achieves >95% reflux suppression within ∼6–10 h, and biosensor responses become detectable within ∼4–10 h at representative inhibitory ranges. Although unvalidated, this integrated configuration may support early-stage triaging of microbial isolates and help guide the discovery of bioactive compounds from under-explored microbial communities. The platform should be viewed as a hypothesis-generating concept rather than a validated tool.
1 January 2019 in Revista da Sociedade Brasileira de Medicina Tropical
The hypothesis that antibiotics evolved from or co-opted bacterial intercellular signaling molecules predicts that signaling-active compounds should exhibit physicochemical properties favorable for drug development. We explored this prediction through a comparative cheminformatics analysis of 74 bacterial signaling molecules — comprising 48 small-molecule diffusible signals, 17 peptide autoinducers and intracellular messengers, and 9 antibiotics with documented signaling activity — against 71 randomly selected drug-like molecules. Small-molecule signaling molecules showed significantly higher Lipinski Rule-of-5 compliance than random drugs (95.8% vs. 73.2%; Odds Ratio = 8.40, 95% CI: 1.86–38.1, p = 0.001; Bonferroni-adjusted p = 0.009), while peptide autoinducers and intracellular messengers showed near-zero compliance (5.9%), confirming that the enrichment is specific to small-molecule diffusible signals. Predicted membrane permeability was over 2-fold higher for small-molecule signals (72.9% vs. 32.4% classified as “Good”), and enrichment was observed across six of seven drug-likeness filters (Enrichment Factors 1.12–1.31). We identified 10 signaling-active molecules with favorable profiles whose direct antibiotic activity has not been systematically tested; six are free of PAINS alerts. This analysis was conducted with substantial AI assistance, molecular properties were compiled from databases rather than computed de novo, and results require independent verification with validated cheminformatics tools. We present these findings as a hypothesis-generating study to stimulate experimental testing of the signaling-first triage concept for antibiotic discovery. For all abbreviations and acronyms used throughout this manuscript, please refer to the Glossary section.